{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:02:03Z","timestamp":1746331323592,"version":"3.40.4"},"reference-count":24,"publisher":"Japanese Society of Internal Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,5,1]]},"DOI":"10.2169\/internalmedicine.4204-24","type":"journal-article","created":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T22:11:05Z","timestamp":1727993465000},"page":"1327-1333","source":"Crossref","is-referenced-by-count":0,"title":["GLUT-1-negative Choroidal Malignant Melanoma with Liver Metastasis Recurrence 12 Years after Surgery without FDG Accumulation in a Recurrent Lesion on FDG-PET\/CT"],"prefix":"10.2169","volume":"64","author":[{"given":"Toyoki","family":"Shimamoto","sequence":"first","affiliation":[{"name":"Department of Liver-Biliary-Pancreatic Disease, Matsuyama Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Ochi","sequence":"additional","affiliation":[{"name":"Department of Liver-Biliary-Pancreatic Disease, Matsuyama Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cao","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Liver-Biliary-Pancreatic Disease, Matsuyama Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiko","family":"Amano","sequence":"additional","affiliation":[{"name":"Department of Liver-Biliary-Pancreatic Disease, Matsuyama Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Liver-Biliary-Pancreatic Disease, Matsuyama Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuaki","family":"Azemoto","sequence":"additional","affiliation":[{"name":"Department of Liver-Biliary-Pancreatic Disease, Matsuyama Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshie","family":"Mashiba","sequence":"additional","affiliation":[{"name":"Department of Liver-Biliary-Pancreatic Disease, Matsuyama Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Surgery, Matsuyama Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Minagawa","sequence":"additional","affiliation":[{"name":"Department of Surgery, Matsuyama Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumi","family":"Ooshiro","sequence":"additional","affiliation":[{"name":"Department of Pathology, Matsuyama Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Kodama","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Matsuyama Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Yokota","sequence":"additional","affiliation":[{"name":"Department of Liver-Biliary-Pancreatic Disease, Matsuyama Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Kath R, Hayungs J, Bornfeld N, Sauerwein W, H\u00f6ffken K, Seeber S. Prognosis and treatment of disseminated uveal melanoma. Cancer 72: 2219-2223, 1993.","DOI":"10.1002\/1097-0142(19931001)72:7<2219::AID-CNCR2820720725>3.0.CO;2-J"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Fujisawa Y, Yoshikawa S, Minagawa A, et al. Clinical and histopathological characteristics and survival analysis of 4594 Japanese patients with melanoma. Cancer Med 8: 2146-2156, 2019.","DOI":"10.1002\/cam4.2110"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Shields CL, Furuta M, Thangappan A, et al. Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes. Arch Ophthalmol 127: 989-998, 2009.","DOI":"10.1001\/archophthalmol.2009.208"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Xu LT, Funchain PF, Bena JF, et al. Uveal melanoma metastatic to the liver: treatment trends and outcomes. Ocul Oncol Pathol 5: 323-332, 2019.","DOI":"10.1159\/000495113"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Crowley NJ, Seigler HF. Late recurrence of malignant melanoma. Analysis of 168 patients. Ann Surg 212: 173-177, 1990.","DOI":"10.1097\/00000658-199008000-00010"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Shien T, Maeda T, Takao T, Yamamoto H, Udaka T, Ohya T. A case ofresected solitaly pulmonary metastasis 25 years after removal of the right eye for choroidal malignant melanoma.  (in Japanese) Nihon Koky\u016bki Geka Gakkai Zasshi (J Jpn Assoc Chest Surg) 16: 635-639, 2002.","DOI":"10.2995\/jacsurg.16.5_635"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Nakamura Y, Asai J, Igaki H, et al. Japanese Dermatological Association Guidelines: outlines of guidelines for cutaneous melanoma 2019. J Dermatol 47: 89-103, 2020.","DOI":"10.1111\/1346-8138.15151"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Pesce A, Piccolo G, Portale TR, Greca GL, Puleo S. Delayed presentation of a metastatic choroidal melanoma to the liver: the latency of an elective metastatic localization. Int J Surg Case Rep 15: 26-29, 2015.","DOI":"10.1016\/j.ijscr.2015.07.011"},{"key":"9","unstructured":"9. Hosonuma K, Sato K, Takagi H, et al. Hepatic metastasis from choroidal malignant melanoma developing 15 years after enucleation. Nihon Shokakibyo Gakkai Zasshi 102: 1201-1206, 2005 (in Japanese)."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Waguri N, Yoshimura A, Suda T, et al. Liver metastasis 30 years after enucleation of the left eyeball for choroidal melanoma. Hepatol Res 30: 232-237, 2004.","DOI":"10.1016\/j.hepres.2004.10.007"},{"key":"11","unstructured":"11. Fukuda T, Shinohara M, Orino S, Saijo T, Ito S, Ii K. A late recurrence case of chroidal malignant melanoma with metastatic lesion in the stomach and the liver on 13 years after surgery.  (in Japanese) Nihon Sh\u014dkaki Naishiky\u014d Gakkai Zasshi (Gastroenterol Endosc) 36: 1597-1605, 1994."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Wakamatsu K, Fukushima S, Minagawa A, et al. Significance of 5-S-cysteinyldopa as a marker for melanoma. Int J Mol Sci 21: 432, 2020.","DOI":"10.3390\/ijms21020432"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Bassi A, Krance SH, Pucchio A, Pur DR, Miranda RN, Felfeli T. The application of artificial intelligence in the analysis of biomarkers for diagnosis and management of uveitis and uveal melanoma: a systematic review. Clin Ophthalmol 16: 2895-2908, 2022.","DOI":"10.2147\/OPTH.S377358"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Umemura H, Yamasaki O, Kaji T, et al. Usefulness of serum 5-S-cysteinyl-dopa as a biomarker for predicting prognosis and detecting relapse in patients with advanced stage malignant melanoma. J Dermatol 44: 449-454, 2017.","DOI":"10.1111\/1346-8138.13651"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Mirshahvalad SA, Zamani-Siahkali N, Pirich C, Beheshti M. A systematic review and meta-analysis on the diagnostic and prognostic values of <sup>18<\/sup>F-FDG PET in uveal melanoma and its hepatic metastasis. Cancers (Basel) 16: 1712, 2024.","DOI":"10.3390\/cancers16091712"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Zamani-Siahkali N, Mirshahvalad SA, Pirich C, Beheshti M. Diagnostic performance of [<sup>18<\/sup>F]F-FDG positron emission tomography (PET) in non-ophthalmic malignant melanoma: a systematic review and meta-analysis of more than 10,000 melanoma patients. Cancers (Basel) 16: 215, 2024.","DOI":"10.3390\/cancers16010215"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Del Carpio LP, Algarra MA, Sabat\u00e9-Llobera A, et al. Differences in glucose metabolic activity in liver metastasis separates two groups of metastatic uveal melanoma patients with different prognosis. Cancer Med 12: 14062-14071, 2023.","DOI":"10.1002\/cam4.6058"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ozaki K, Harada K, Terayama N, Kosaka N, Kimura H, Gabata T. FDG-PET\/CT imaging findings of hepatic tumors and tumor-like lesions based on molecular background. Jpn J Radiol 38: 697-718, 2020.","DOI":"10.1007\/s11604-020-00961-1"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Park SG, Lee JH, Lee WA, Han KM. Biologic correlation between glucose transporters, hexokinase-II, Ki-67 and FDG uptake in malignant melanoma. Nucl Med Biol 39: 1167-1172, 2012.","DOI":"10.1016\/j.nucmedbio.2012.07.003"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. D\u016fra M, N\u011bmejcov\u00e1 K, Jak\u0161a R, et al. Expression of Glut-1 in malignant melanoma and melanocytic nevi: an immunohistochemical study of 400 cases. Pathol Oncol Res 25: 361-368, 2019.","DOI":"10.1007\/s12253-017-0363-7"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Maa\u00dfen T, Vardanyan S, Brosig A, et al. Monosomy-3 alters the expression profile of the glucose transporters GLUT1-3 in uveal melanoma. Int J Mol Sci 21: 9345, 2020.","DOI":"10.3390\/ijms21249345"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Strobel K, Bode B, Dummer R, et al. Limited value of <sup>18<\/sup>F-FDG PET\/CT and S-100B tumour marker in the detection of liver metastases from uveal melanoma compared to liver metastases from cutaneous melanoma. Eur J Nucl Med Mol Imaging 36: 1774-1782, 2009.","DOI":"10.1007\/s00259-009-1175-0"},{"key":"23","unstructured":"23. Avril N. GLUT1 expression in tissue and <sup>18<\/sup>F-FDG uptake. J Nucl Med 45: 930-932, 2004."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Weber J, Mandala M, Del Vecchio  M, et al. Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma. N Engl J Med 377: 1824-1835, 2017.","DOI":"10.1056\/NEJMoa1709030"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/9\/64_4204-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T04:00:56Z","timestamp":1746244856000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/9\/64_4204-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,1]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4204-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"type":"print","value":"0918-2918"},{"type":"electronic","value":"1349-7235"}],"subject":[],"published":{"date-parts":[[2025,5,1]]},"article-number":"4204-24"}}